VHCP Management EG, LLC's Net Worth

$123 Million

Estimate Recalculated Apr 22, 2024 03:38PM EST

Who is VHCP Management EG, LLC?

VHCP Management EG, LLC has an estimated net worth of $123 Million. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., Tricida, Inc., and Vistagen Therapeutics, Inc..

SEC CIK

VHCP Management EG, LLC's CIK is 0001808518

Past Insider Trading and Trends

2022 was VHCP Management EG, LLC's most active year for acquiring shares with 46 total transactions. VHCP Management EG, LLC's most active month to acquire stocks was the month of May. 2022 was VHCP Management EG, LLC's most active year for disposing of shares, totalling 4 transactions. VHCP Management EG, LLC's most active month to dispose stocks was the month of September. 2022 saw VHCP Management EG, LLC paying a total of $46,709,157.51 for 4,528,657 shares, this is the most they've acquired in one year. In 2022 VHCP Management EG, LLC cashed out on 6,511,540 shares for a total of $3,554,946.58, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tricida, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-63.23%
-6.45M
$0.54
-$3,501,546.58
3.75M
Oct 24 - Oct 26
Form 4
+3.57%
351.87K
$10.68
$3,756,273.14
10.2M
Oct 18 - Oct 19
Form 4
+1.81%
174.97K
$11.68
$2,043,302.16
9.85M
Oct 13 - Oct 17
Form 4
+1.41%
134.21K
$11.91
$1,597,983.46
9.68M
Oct 7 - Oct 11
Form 4
+2.39%
223.1K
$11.81
$2,634,811.00
9.54M
Oct 4
Form 4
+4.92%
436.92K
$10.75
$4,697,069.76
9.32M
Sep 29 - Oct 3
Form 4
+7.08%
587.21K
$8.90
$5,225,027.84
8.88M
Sep 26 - Sep 28
Form 4
+9.03%
686.71K
$11.53
$7,918,744.29
8.29M
Sep 2 - Sep 7
Form 4
+0.66%
50K
$12.20
$610,000.00
7.61M
Aug 30
Form 4
+0.25%
18.9K
$9.21
$174,069.00
7.56M
Jul 29
Form 4
+0.99%
74.2K
$9.26
$687,181.05
7.54M
Jul 21 - Jul 25
Form 4
+2.05%
150K
$9.18
$1,377,250.00
7.46M
Jul 18 - Jul 20
Form 4
+1.31%
94.57K
$9.88
$934,815.33
7.31M
Jul 12 - Jul 14
Form 4
+1.24%
88.2K
$9.61
$847,230.00
7.22M
Jul 1 - Jul 5
Form 4
+0.89%
62.87K
$9.76
$613,509.92
7.13M
Jun 28 - Jun 30
Form 4
+7.48%
492.02K
$10.37
$5,101,091.60
7.07M
Jun 22 - Jun 24
Form 4
+0.09%
5.95K
$9.69
$57,665.19
6.58M
Jun 16
Form 4
+1.83%
118.05K
$8.57
$1,011,461.14
6.57M
Jun 10 - Jun 14
Form 4
+10.03%
588.02K
$9.65
$5,672,963.18
6.45M
Jun 7 - Jun 9
Form 4
+3.36%
190.87K
$9.16
$1,748,709.45
5.87M
Jun 2 - Jun 6
Form 3
—
0
—
—
0
No matching records found

Vistagen Therapeutics, Inc. (VTGN) Snapshot price: $4.87

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.29%
-60.00K
$0.89
-$53,400.00
20.64M
Jul 12
Form 3
—
0
—
—
0
No matching records found

KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.48

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 20
Form 4
+1.82%
86.05K
$14.62
$1,257,828.78
4.82M
Feb 6 - Feb 8
Form 4
+1.89%
88.1K
$14.47
$1,274,792.53
4.74M
Jan 30
Form 4
+2.01%
91.8K
$14.05
$1,289,802.42
4.65M
Jan 25 - Jan 29
Form 4
+2.22%
99.13K
$12.53
$1,241,684.52
4.56M
Jan 22 - Jan 24
Form 4
+3.33%
143.6K
$12.55
$1,801,601.80
4.46M
Jan 17 - Jan 19
Form 4
+0.61%
26.25K
$12.72
$333,779.23
4.32M
Jan 11 - Jan 16
Form 4
+3.32%
137.7K
$12.54
$1,726,456.92
4.29M
Jan 8 - Jan 10
Form 4
+1.45%
59.37K
$12.14
$720,543.04
4.15M
Jan 3 - Jan 4
Form 4
+14.52%
519.02K
$12.46
$6,465,649.95
4.09M
Dec 27 - Dec 29
Form 3
—
0
—
—
0
No matching records found